Retatrutide Clinical Trials

added blog Health

2025-10-17 18:46:16 -

A. Weight Loss Benefits Retatrutide has demonstrated substantial weight loss potential across multiple trials: Phase 2 Trial (New England Journal of Medicine, 2023):A 48-week study involving 338 adults with obesity showed the following average weight reductions: 1 mg dose: 8.7% 4 mg dose: 17.1% 8 mg dose: 22.8% 12 mg dose: 24.2%(Placebo group: 2.1%) Participants also...

0 Comments 0 Shares 164 Views 0 Reviews